edotreotide has been researched along with Experimental Neoplasms in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Eltschinger, V; Reubi, JC; Schottelius, M; Schwaiger, M; Wester, HJ | 1 |
Alke, A; Essler, M; Henriksen, G; Miederer, M; Mossbrugger, I; Quintanilla-Martinez, L; Senekowitsch-Schmidtke, R | 1 |
2 other study(ies) available for edotreotide and Experimental Neoplasms
Article | Year |
---|---|
N-terminal sugar conjugation and C-terminal Thr-for-Thr(ol) exchange in radioiodinated Tyr3-octreotide: effect on cellular ligand trafficking in vitro and tumor accumulation in vivo.
Topics: Animals; Biological Transport; Cell Line; Cricetinae; Cricetulus; Female; Glucose; Glycosylation; Humans; Iodine Radioisotopes; Isotope Labeling; Ligands; Maltose; Mice; Mice, Nude; Neoplasms, Experimental; Octreotide; Radiopharmaceuticals; Receptors, Somatostatin; Structure-Activity Relationship; Trisaccharides | 2005 |
Preclinical evaluation of the alpha-particle generator nuclide 225Ac for somatostatin receptor radiotherapy of neuroendocrine tumors.
Topics: Alpha Particles; Animals; Mice; Mice, Nude; Neoplasms, Experimental; Neuroendocrine Tumors; Octreotide; Radioisotopes; Radiopharmaceuticals; Rats; Receptors, Somatostatin; Xenograft Model Antitumor Assays | 2008 |